Acurastem Inc.
Overview
Acurastem Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). The company is leveraging cutting-edge stem cell and small molecule technologies to address the underlying causes of these conditions.
Therapeutic areas
Neurodegenerative diseasesAmyotrophic lateral sclerosis (ALS)
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Acurastem Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.